Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Nur Dikmen has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Comparing Reintervention Factors in Acute Deep Vein Thrombosis and Post-Thrombotic Syndrome

    by Ahmet Kayan, Ali Fuat Karaçuha, Ali Batuhan Yenigün, Evren Özçınar, Çağdaş Baran, Fatma Akça, Cahit Sarıca, Mustafa Şırlak, Nur Dikmen, Ali İhSan Hasde, et al.

    Background: Acute iliofemoral deep vein thrombosis (DVT) and post-thrombotic syndrome (PTS) are characterized by significant morbidity due to impaired venous drainage. Although technical success in endovascular interventions is increasing, the need for reintervention due to complications like stent thrombosis and restenosis remains the primary obstacle to long-term clinical success.Objective: This study aims to compare clinical characteristics and intraoperative findings requiring reintervention in acute DVT and PTS patients to optimize patient-specific follow-up and management strategies.Materials and Methods: We retrospectively evaluated 400 patients (184 Acute DVT, 216 PTS) who underwent iliofemoral venous stenting. A subgroup of 111 patients (51 Acute DVT, 60 PTS) undergoing reintervention for clinical or radiological failure was analyzed. Groups were statistically compared regarding demographics, reintervention indications, and intraoperative findings.Results: The 12-month primary patency rates were 72.5% for Acute DVT and 68.3% for PTS. Among those requiring reintervention, the PTS group had significantly higher rates of recent surgery/trauma (53.3% vs. 27.5%; p=0.010) and recurrent venous ulcers (48.3% vs. 23.5%; p=0.012). Intraoperatively, in-stent restenosis (ISR) was more frequent in the PTS group (66.7% vs. 47.1%; p=0.038). In the Acute DVT group, masked anatomical issues predominated, specifically contralateral outflow obstruction (15.7% vs. 3.3%; p=0.042) and untreated additional venous lesions (47.1% vs. 23.3%; p=0.015). Secondary patency rates remained high in both groups (90.2% and 85.1%).Conclusion: Reintervention etiologies for acute DVT and PTS differ significantly. Failure in PTS is associated with chronic ISR and ulcer recurrence, while missed anatomical lesions during the index procedure are decisive in acute DVT. Extensive anatomical mapping in acute cases and aggressive restenosis monitoring in PTS are critical for long-term success.

  • Open Access

    Kalp ve Damar Cerrahi - Konjenital Kalp Cerrahisi (Cilt 3)

    by Merjem Purelku, Gamze Tanrıverdi, Ayşe Sarıoğlu, Canan Ayabakan, Osman Yılmaz, Tuğçin Bora Polat, Merve Maze Aydemir, Feyza Ayşenur Paç, Serçin Özkök, Uğur Dikkaş, et al.

  • Çocuklarda Görülen Kardiyak Tümörler

    by Nur Dikmen, Zeynep Eyileten

  • Predictors of Mortality Correlated with the SOFA Score in Pediatric VA-ECMO Patients

    by Nur Dikmen, Zeynep Eyıleten, Oğuzhan Durmaz, Evren Özçınar, Burcu Arıcı, Ahmet Kayan, Ali Fuat Karaçuha, Merve Havan, Fatma Akça, Tayfun Uçar, et al.

    Background: The objective of this study was to analyze mortality predictors in pediatric VA-ECMO patients, correlating these predictors with the pediatric sequential organ failure assessment score (pSOFA). Aim: To enhance prognostic accuracy and support individualized clinical decision-making by evaluating the correlations between mortality predictors and pediatric sequential organ failure assessment (pSOFA) scores in pediatric VA-ECMO patients. Methods: We conducted a retrospective analysis of 80 consecutive pediatric VA-ECMO cases treated at our center between April 2018 and October 2021. Data collection included patient demographics, clinical features, pSOFA scores, and estimated mortality risks. Survival impacts and morbidity factors were also assessed. The overall decannulation and hospital discharge rates were recorded, with a particular focus on patients with congenital cardiac diseases and those experiencing postcardiotomy low cardiac output, who showed the highest survival rates. Results: Our analysis revealed that certain variables significantly influenced survival outcomes in pediatric VA-ECMO patients. These variables included age, weight, genetic disorders, inotropic support, inhaled nitric oxide (NO) usage, hemodiafiltration, duration of hospital stay, active cardiopulmonary resuscitation during cannulation, and various biochemical markers. Notably, the mean pSOFA scores were significantly lower in survivors compared to non-survivors (9.22 ± 1.43 vs. 13.06 ± 2.69, respectively). Overall decannulation and hospital discharge rates were 60% and 48.75%, respectively, with the highest rates observed in patients with congenital cardiac diseases and postcardiotomy low cardiac output (84.6% and 76.9%, respectively). Furthermore, several mortality predictors were identified, which correlated strongly with pSOFA scores. These predictors included the need for inotropic support, elevated levels of lactate and creatinine, a low protein/albumin ratio, and a low pH prior to cannulation. These findings underscore the critical importance of assessing the severity of organ failure and the overall clinical status when determining mortality risk in pediatric VA-ECMO patients. Conclusion: This study offers valuable insights into the association between pSOFA scores and mortality predictors in pediatric ECMO cases. The significant correlation between higher pSOFA scores and increased mortality highlights the necessity for comprehensive risk assessment and vigilant monitoring of clinical status to optimize patient outcomes. Our findings support the integration of pSOFA scores into routine clinical practice for more effective prognostication and individualized patient management in pediatric VA-ECMO.

  • Open Access

    Comparative Outcomes of Catheter-Directed Thrombolysis and Open Surgical Revascularization in Early-Stage Acute Limb Ischemia: Real-World Evidence from a Retrospective Cohort Study

    by Mehmet Cahit Sarıcaoğlu, Salih Anil Boga, Ismet Onur Taniyan, Melisa Kandemir, Fatma Akça, Ahmet Kayan, Ebru Ozturk, Nur Dikmen, Ali Ihsan Hasde, Cagdas Baran, et al.

    Background: Acute limb ischemia (ALI) is a vascular emergency where timely revascularization is crucial for limb salvage and survival. While open surgical revascularization (OSR) has been the traditional standard, catheter-directed thrombolysis (CDT) has emerged as a minimally invasive alternative. Comparative real-world evidence in early-stage ALI (Rutherford I–IIa) remains limited. Methods: We conducted a retrospective single-center cohort study including 36 patients with ALI treated between 2019 and 2023 (OSR: n=24; CDT: n=12). Demographics, comorbidities, procedural details, and outcomes were analyzed. The primary endpoint was a composite of in-hospital mortality, primary patency, and secondary patency. Secondary endpoints included amputation, cerebrovascular events, renal function, and hospital stay. Effect sizes with 95% confidence intervals were reported alongside p-values to address type II error risk. Results: Baseline characteristics were comparable between groups. Both OSR and CDT significantly improved ankle-brachial index (0.64 ± 0.43 to 0.93 ± 0.33, p< 0.001) and postoperative arterial patency. At 12 months, primary patency was 66.7% (OSR) vs. 50.0% (CDT), and secondary patency was 79.2% vs. 75.0% (p>0.05). Major amputation (12.5% vs. 16.7%) and mortality (8.3% vs. 16.7%) rates did not differ significantly. Hospital stay was longer after OSR (7.29 ± 4.58 vs. 6.08 ± 8.75 days, p=0.038). Fibrinogen levels decreased significantly during CDT, but no major bleeding events occurred. Conclusion: Both OSR and CDT provide effective revascularization in early ALI, with comparable limb salvage and survival outcomes. CDT offers a minimally invasive alternative with acceptable safety when accompanied by careful monitoring, whereas OSR remains a reliable option with immediate reperfusion. Larger multicenter studies are needed to refine patient selection and optimize treatment algorithms.

  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akca, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Guven, Oguzhan Durmaz, Salih Anil Boga, Ali Fuat Karacuha, et al.

    Background: Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair (TEVAR) to include arch lesions. In situ needle fenestration (ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and Methods: A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024. The median age of the patients was 51,33 years (±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 min (range: 126–302). Two patients experienced a minor hematoma at the access site. Mortality was observed in one patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia. No procedure-related endoleak was observed during the intervention; however, eight patients required reintervention in the descending aorta. Conclusions: ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.


  • Open Access

    Total Endovascular Aortic Arch Repair Using In Situ Needle Triple Fenestration and Selective Cerebral Perfusion: Single-Center Results

    by Evren Ozcinar, Fatma Akça, Mehmet Cahit Saricaoglu, Ali Ihsan Hasde, Nur Dikmen, Onur Buyukcakir, Aysegul Güven, Oğuzhan Durmaz, Salih Anıl Boğa, Ali Fuat Karacuha, et al.

    Background:Advances in stent grafts and endovascular techniques have expanded the indications for thoracic endovascular aortic repair(TEVAR) to include arch lesions.In situ needle fenestration(ISNF) has emerged as a promising technique for revascularizing supra-aortic branches. The aim of this study is to evaluate the safety and efficacy of triple in situ needle fenestration during TEVAR for aortic arch pathologies in a single-center experience. Materials and methods:A retrospective analysis was conducted on fifteen patients who underwent in situ triple fenestration TEVAR between June 2023 and March 2024.The median age of the patients was 51,33 years(±19.69) and twelve of the patients were male. All procedures were performed under general anesthesia in a hybrid operating room. Ethical approval was obtained from the institutional review board, and informed consent was received from all participants. Results: Primary technical success was achieved in all cases (15/15, 100%). The mean operation time was 197.33 minutes (range: 126–302).Two patient experienced a minor hematoma at the access site. Mortality was observed in 1 patient (6.66%) during the 30-day follow-up period. The total hospital stay averaged 7 ± 3.36 days. One patient had a transient ischemic attack, but there were no incidents of stroke or spinal cord ischemia.No procedure-related endoleak was observed during the intervention; however, 8 patients required reintervention in the descending aorta. Conclusion:ISNF may be an effective and feasible method for revascularizing arch vessels, with low rates of early mortality and stroke when performed by experienced practitioners. However, larger multicenter studies with longer follow-up are needed to confirm the durability and long-term outcomes of this technique.


  • Open Access

    Comparison of atherectomy and drug-coated balloon in critical femoropopliteal lesions mid-term results

    by Ali Fuat Karacuha, Ahmet Kayan, Cagdas Baran, Mehmet Cahit Saricaoglu, Nur Dikmen, Evren Ozcinar, Mustafa Sirlak, Sadik Eryilmaz

    Aim: Peripheral artery disease (PAD) restricts blood flow to the lower limbs, causing pain, reduced mobility, and critical limb ischemia, leading to severe complications. While atherectomy and drug-coated balloon (DCB) angioplasty are effective revascularization methods, restenosis remains challenging, especially in calcified lesions. This study aims to compare mid-term outcomes, including primary patency, complication rates, and re-intervention needs, between atherectomy combined with DCB angioplasty and DCB-only treatment in patients with femoropopliteal artery disease.Material and Methods: We conducted a retrospective review of 144 PAD patients treated between March 2020 and March 2022. Patients were divided into two groups: 66 received atherectomy plus DCB, while 78 underwent DCB-only angioplasty. Baseline characteristics, lesion parameters, and clinical outcomes, including primary patency and complication rates, were assessed at 6, 12, and 24 months post-procedure using color Doppler ultrasonography (CDUS).Results: At 6 months, patency rates were similar across both groups, but the atherectomy + DCB group showed significantly higher patency at 12 months (p=0.045) and 24 months (p=0.04). Complications, including distal embolism, arterial dissection, and pseudoaneurysm, were comparable between groups. The atherectomy + DCB group also had lower target lesion revascularization rates, suggesting reduced need for re-interventions.Conclusion: Atherectomy combined with DCB angioplasty yields superior mid-term patency compared to DCB alone, especially in patients with calcified lesions. This approach optimizes drug delivery and reduces re-intervention needs, offering a viable option for complex femoropopliteal PAD. Future randomized trials are recommended to confirm these findings and refine patient-specific treatment strategies.


  • Open Access

    Evaluating the Efficacy and Safety of Transbrachial Access in Iliac Endovascular Interventions: A Comprehensive Analysis

    by Nur Dikmen, Evren Ozcinar

    Background: This study evaluates the use of transbrachial artery access for endovascular treatment of iliac artery lesions, with a focus on its efficacy and safety outcomes. Methods: Between January 2020 and May 2023, 94 patients with iliac artery disease underwent endovascular procedures via a transbrachial access approach. The majority of patients (n = 68; 72%) presented with lifestyle-limiting claudication (Rutherford category 3). Diagnostic angiography identified Transatlantic Inter-Society Consensus II (TASC) C/D lesions in 54 patients (57%). The primary outcome was achieving technical success with transbrachial access, while secondary outcomes included secondary technical success (necessitating additional transfemoral access), access site complications, and cerebrovascular events. Results: The primary and secondary technical success rates were 82% and 92%, respectively. Access site-related adverse events occurred in 12 patients (12%), primarily hematomas (seven events, 7.4%; two requiring transfusion) and pseudoaneurysms (four events, 4.2%). Thrombotic occlusion was observed in one patient (1%), and brachial arterial bleeding requiring urgent surgical intervention occurred in three patients (3.2%). Neurological complications included two cerebrovascular events (2.1%), although no permanent or transient median nerve injuries were observed. Conclusions: The transbrachial approach represents a potential alternative to the femoral artery route in patients with iliac artery lesions. However, the relatively higher incidence of access site complications may limit its broader application in clinical practice.


  • Open Access

    [MSB-36] Long-Term Results of Covered Endovascular Aortic Bifurcation Repair in Complex Aortoiliac Disease: A Two-Year Follow-Up

    by Nur Dikmen, Evren Ozcinar, Fatma Akça, Emre Şen, Ali Fuat Karacuha, Ahmet Kayan, Levent Yazıcıoğlu

    Objective: This study aimed to investigate the two-year outcomes of covered endovascular reconstruction of the aortic bifurcation (CERAB) in patients with complex aortoiliac occlusive disease. Methods: This retrospective study was conducted with 40 patients (33 males, 7 females) with aortoiliac occlusive disease categorized as TASC (Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease) II B, C, and D, based on computed tomography angiography findings. All patients underwent the CERAB procedure. The study assessed procedural outcomes, including clinical and symptomatic improvements, as well as patency rates, over a two-year follow-up period. Results: The technical success rate was 100% across all procedures. At 36 months, the overall primary patency, assisted primary patency, and secondary patency rates were 85%, 90%, and 92.5%, respectively. Conclusions: The two-year outcomes of this study suggest that CERAB offers patency rates comparable to those reported in other studies for complex aortoiliac occlusive diseases. The procedure showed favorable patency rates, particularly for more advanced TASC II B, C, and D lesions.